DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 125 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $599,426 | +14.3% | 40,584 | 0.0% | 0.24% | +14.2% |
| Q2 2023 | $524,345 | +226.6% | 40,584 | +148.0% | 0.21% | +193.1% |
| Q1 2023 | $160,531 | -7.8% | 16,364 | 0.0% | 0.07% | -12.2% |
| Q4 2022 | $174,113 | +1.8% | 16,364 | 0.0% | 0.08% | -1.2% |
| Q3 2022 | $171,000 | -78.4% | 16,364 | -79.6% | 0.08% | -67.3% |
| Q2 2021 | $792,000 | +0.3% | 80,400 | 0.0% | 0.25% | -15.9% |
| Q1 2021 | $790,000 | +45.0% | 80,400 | -34.4% | 0.30% | +43.8% |
| Q4 2020 | $545,000 | +3.0% | 122,555 | 0.0% | 0.21% | -9.9% |
| Q3 2020 | $529,000 | -65.4% | 122,555 | -29.0% | 0.23% | -69.9% |
| Q2 2020 | $1,531,000 | +93.1% | 172,555 | -23.2% | 0.77% | +25.3% |
| Q1 2020 | $793,000 | -3.2% | 224,555 | +56.8% | 0.62% | +30.7% |
| Q4 2019 | $819,000 | – | 143,180 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |